RUTIGLIANO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 3.815
AS - Asia 1.507
EU - Europa 1.325
SA - Sud America 337
AF - Africa 69
AN - Antartide 1
OC - Oceania 1
Totale 7.055
Nazione #
US - Stati Uniti d'America 3.744
SG - Singapore 582
IT - Italia 483
CN - Cina 367
BR - Brasile 268
SE - Svezia 194
RU - Federazione Russa 173
HK - Hong Kong 168
VN - Vietnam 139
DE - Germania 128
FI - Finlandia 74
FR - Francia 70
GB - Regno Unito 65
CA - Canada 43
IN - India 42
UA - Ucraina 37
BD - Bangladesh 34
NL - Olanda 28
ID - Indonesia 23
MX - Messico 21
AR - Argentina 20
JP - Giappone 20
BE - Belgio 19
CO - Colombia 18
TR - Turchia 18
PK - Pakistan 17
SA - Arabia Saudita 17
ZA - Sudafrica 17
IQ - Iraq 16
CI - Costa d'Avorio 15
VE - Venezuela 12
ES - Italia 10
UZ - Uzbekistan 10
PL - Polonia 7
IR - Iran 6
MA - Marocco 6
PH - Filippine 6
TN - Tunisia 6
AT - Austria 5
IE - Irlanda 5
KR - Corea 5
LT - Lituania 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DZ - Algeria 4
EC - Ecuador 4
NP - Nepal 4
AO - Angola 3
AZ - Azerbaigian 3
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
HU - Ungheria 3
KE - Kenya 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
RE - Reunion 2
RO - Romania 2
SY - Repubblica araba siriana 2
ZW - Zimbabwe 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 7.055
Città #
Ashburn 478
Fairfield 352
Singapore 332
Chandler 259
Woodbridge 249
Seattle 178
Houston 173
Hong Kong 167
San Jose 165
Beijing 151
Cambridge 145
Nyköping 144
Wilmington 127
Ann Arbor 122
Milan 105
Bari 100
New York 85
Los Angeles 72
Jacksonville 68
Munich 54
Ho Chi Minh City 50
Rome 50
Dallas 46
Lauterbourg 42
Roxbury 42
Lawrence 40
São Paulo 33
Council Bluffs 29
Nanjing 29
Helsinki 27
Princeton 27
Brooklyn 26
Des Moines 25
Santa Clara 25
Hanoi 24
Inglewood 23
Boardman 22
Atlanta 21
Dearborn 20
Buffalo 19
Toronto 19
Brussels 18
Chicago 18
Columbus 17
Jakarta 17
Dong Ket 16
Frankfurt am Main 16
Orem 16
Turku 16
Abidjan 15
London 15
Figino 13
Shenyang 13
San Diego 12
Falkenstein 11
Manduria 11
Nanchang 11
Phoenix 11
The Dalles 11
Tokyo 11
Caracas 10
Moscow 10
Rio de Janeiro 10
San Francisco 10
Tianjin 10
Changsha 9
Hebei 9
Indianapolis 9
Mexico City 9
Paris 8
Pune 8
Amsterdam 7
Boston 7
Brasília 7
Chennai 7
Johannesburg 7
Montreal 7
Naples 7
Nuremberg 7
Redwood City 7
Tashkent 7
Belo Horizonte 6
Catania 6
Charlotte 6
Curitiba 6
Riyadh 6
Augusta 5
Baghdad 5
Bitonto 5
Bogotá 5
Denver 5
Detroit 5
Dublin 5
Guangzhou 5
Haiphong 5
Hefei 5
Jeddah 5
Jiaxing 5
Kunming 5
Noicattaro 5
Totale 4.705
Nome #
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 464
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 229
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 228
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 215
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 214
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 211
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 203
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 200
Isolation and characterization of cancer stem cells in renal cell carcinoma. 196
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 196
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 178
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 171
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 169
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 169
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 158
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 150
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 149
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 145
Emerging urinary markers of renal injury in obstructive nephropathy. 140
Analisi dei fattori critici nello studio MALDI-TOF del profilo peptidico urinario in soggetti sani e con cancro alla prostata 136
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 136
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 132
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 132
Cryopreserved Penile Tunica Albuginea for Allotransplantation: A Morphological and Ultrastructural Investigation. 131
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 127
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 127
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 123
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 116
The Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase 112
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 111
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 108
Regulation of TGF-beta 1 expression by Androgen Deprivation Therapy of prostate cancer 107
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 105
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 104
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 103
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 101
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 99
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 98
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 97
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 95
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 92
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 92
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 90
null 86
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 85
LOSS OF LKB1 EXPRESSION IS AN EARLY MOLECULAR EVENT IN PROSTATE CARCINOGENESIS 79
To007 Adult Renal Stem/progenitor Cells Express Long Non-coding Rnas Involved In Wnt And The Bmp Signaling Pathway 77
null 74
SP168 ARPCS CAN REVERT LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION OF ENDOTHELIAL CELLS 67
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma 62
The Role of MUC1 in Renal Cell Carcinoma. Biomolecules. 62
null 61
null 49
null 46
null 36
null 16
Totale 7.259
Categoria #
all - tutte 28.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022375 22 30 8 13 18 26 23 19 20 50 65 81
2022/2023619 96 106 48 63 48 86 4 65 68 6 16 13
2023/2024242 22 40 10 18 27 86 6 5 2 9 6 11
2024/20251.188 30 22 69 59 36 98 190 120 44 67 155 298
2025/20262.371 408 122 114 206 320 145 239 77 223 225 78 214
2026/2027349 349 0 0 0 0 0 0 0 0 0 0 0
Totale 7.259